Eli Lilly and Co plummeted, Is the weight loss drug hitting a wall?
The management said that there is "no problem" with demand, but wholesalers prioritize reducing inventory. Will even the "hot-selling" weight-loss drugs face a demand crisis?
Roche's Antibody Against Alzheimer's Looks the Best Yet -- Barrons.com
AbbVie's Deal for Alzheimer's Antibody Raises Curtain for Roche News on Wednesday -- Barrons.com
Eli Lilly and Co Options Spot-On: On October 31st, 103.23K Contracts Were Traded, With 345.79K Open Interest
On October 31st ET, $Eli Lilly and Co(LLY.US)$ had active options trading, with a total trading volume of 103.23K options for the day, of which put options accounted for 42.0% of the total
Barclays Maintains Overweight on Eli Lilly, Lowers Price Target to $975
Eli Lilly 'Well-Positioned' for Growth Into 2025 Despite Q3 Volatility, UBS Says